Recent Quarter Total Invested
$285.44 M
Recent Quarter Institutional Ownership Percentage
86.25%
Total Invested of Last Quarter
$240.07 M
Ownership Percentage of Last Quarter
86.9%
Inozyme Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 5.67 M | $29.67 M | -0.96% | 8.97% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2024 | 4.49 M | $23.51 M | 0.00% | 7.10% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 4.28 M | $22.39 B | 0.00% | 6.76% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 4.13 M | $21.62 M | 5.04% | 6.53% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 3.80 M | $19.89 M | 2.83% | 6.01% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.49 M | $18.26 M | 100.00% | 5.52% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 3.26 M | $17.05 M | -2.73% | 5.15% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 2.82 M | $14.76 M | -1.19% | 4.46% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 2.44 M | $12.75 M | 0.00% | 3.85% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.74 M | $9.12 M | -2.43% | 2.76% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 1.56 M | $8.17 M | 0.00% | 2.47% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.37 M | $7.16 M | 20.04% | 2.16% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 1.19 M | $6.23 M | -18.57% | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.17 M | $6.13 M | 1.69% | 1.85% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 1.12 M | $5.86 M | 0.00% | 1.77% |
| STATE STREET CORP | 11/14/2024 | 1.05 M | $5.49 M | 5.04% | 1.66% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.00 M | $5.25 M | 0.24% | 1.59% |
| KNOTT DAVID M JR | 11/13/2024 | 564,549 | $2.95 M | 0.00% | 0.89% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 447,317 | $2.34 M | 23.61% | 0.71% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 446,152 | $2.33 M | 17.39% | 0.71% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 260,719 | $1.36 M | 11.91% | 0.41% |
| UBS OCONNOR LLC | 11/14/2024 | 226,232 | $1.18 M | 10.24% | 0.36% |
| OVERBROOK MANAGEMENT CORP | 11/08/2024 | 219,326 | $1.15 M | 0.00% | 0.35% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 202,729 | $1.06 M | 26.01% | 0.32% |
| PALE FIRE CAPITAL SE | 11/12/2024 | 188,537 | $986,049 | 384.66% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 164,800 | $861,904 | -12.27% | 0.26% |
| MORGAN STANLEY | 11/14/2024 | 158,846 | $830,763 | 101.33% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 155,696 | $814,288 | -18.44% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 143,158 | $748,716 | 0.00% | 0.23% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 121,614 | $636,041 | -13.15% | 0.19% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 78,400 | $410,032 | 100.00% | 0.12% |
| RHUMBLINE ADVISERS | 11/12/2024 | 76,817 | $401,740 | -0.24% | 0.12% |
| BARCLAYS PLC | 11/19/2024 | 76,730 | $401,000 | 261.37% | 0.12% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 71,086 | $371,780 | 24.49% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2024 | 49,560 | $259,199 | 91.39% | 0.08% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 48,056 | $251,000 | -12.92% | 0.08% |
| ALPS ADVISORS INC | 11/12/2024 | 44,562 | $233,059 | -7.67% | 0.07% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 35,402 | $185,000 | -13.51% | 0.06% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 34,990 | $182,998 | 7.17% | 0.06% |
| JPMORGAN CHASE & CO | 11/08/2024 | 28,928 | $151,293 | 31.03% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 28,364 | $148,344 | 16.22% | 0.04% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 28,093 | $146,926 | 100.00% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 27,949 | $146,173 | 0.00% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 27,641 | $144,562 | -0.61% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 25,764 | $134,745 | 63.34% | 0.04% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 24,534 | $128,313 | 8.02% | 0.04% |
| BAILARD, INC. | 10/30/2024 | 24,300 | $127,089 | 0.00% | 0.04% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 24,300 | $127,089 | -17.91% | 0.04% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 20,700 | $108,261 | -3.39% | 0.03% |
| RESOURCES INVESTMENT ADVISORS, LLC. | 11/06/2024 | 20,000 | $104,600 | 51.52% | 0.03% |
Inozyme Pharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of INZY shares?
During the previous two years, 97 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.67 M
Pivotal bioVenture Partners Investment Advisor LLC: 4.49 M
Sofinnova Investments, Inc.: 4.28 M
EVENTIDE ASSET MANAGEMENT, LLC: 4.13 M
Rock Springs Capital Management LP: 3.8 M
BlackRock Funding, Inc. /DE: 3.49 M
-
What percentage of Inozyme Pharma, Inc. stock is owned by institutional investors?
86.25% of Inozyme Pharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at INZY ?
Institutional investors have bought a total of 53.79 M shares in the last 24 months. This purchase volume represents approximately $151.67 M in transactions.